Data-driven haemodynamic response function extraction using Fourier-wavelet regularised deconvolution

Autor: Roerdink Jos BTM, Hoogduin Hans, Wink Alle

Publikováno v: BMC Medical Imaging, Vol 8, Iss 1, p 7 (2008)

Abstract Background We present a simple, data-driven method to extract haemodynamic response functions (HRF) from functional magnetic resonance imaging (fMRI) time series, based on the Fourier-wavelet regularised deconvolution (ForWaRD) technique. HR

Externí odkaz: https://doaj.org/article/0c00219ec54b4145a3a8a68935a4a569

Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors.

Autor: Ridnour LA; Cancer Innovation Laboratory, CCR, NCI, NIH, Frederick, Maryland, USA., Cheng RY; Cancer Innovation Laboratory, CCR, NCI, NIH, Frederick, Maryland, USA., Kedei N; Collaborative Protein Technology Resource (CPTR) Nanoscale Protein Analysis, OSTR, CCR, NCI, NIH, Bethesda, Maryland, USA., Somasundaram V; Cancer Innovation Laboratory, CCR, NCI, NIH, Frederick, Maryland, USA., Bhattacharyya DD; Cancer Innovation Laboratory, CCR, NCI, NIH, Frederick, Maryland, USA., Basudhar D; Cancer Innovation Laboratory, CCR, NCI, NIH, Frederick, Maryland, USA., Wink AL; Optical Microscopy and Analysis Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, and., Walke AJ; Optical Microscopy and Analysis Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, and., Kim C; Optical Microscopy and Analysis Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, and., Heinz WF; Optical Microscopy and Analysis Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, and., Edmondson EF; Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, Maryland, USA., Butcher DO; Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, Maryland, USA., Warner AC; Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, Maryland, USA., Dorsey TH; Laboratory of Human Carcinogenesis, CCR, NCI, NIH, Bethesda, Maryland, USA., Pore M; Imaging Mass Cytometry Frederick National Laboratory for Cancer Research, and., Kinders RJ; Office of the Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, Maryland, USA., Lipkowitz S; Women's Malignancy Branch CCR, NCI, NIH, Bethesda, Maryland, USA., Bryant RJ; Department of Urology, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom., Rittscher J; Institute of Biomedical Engineering, Big Data Institute, Ludwig Oxford Branch, University of Oxford, Oxford, United Kingdom., Wong ST; Houston Methodist Neal Cancer Center, Weill Cornell Medical College, Houston Methodist Hospital, Houston, Texas, USA., Hewitt SM; Laboratory of Pathology CCR, NCI, NIH, Bethesda, Maryland, USA., Chang JC; Houston Methodist Neal Cancer Center, Weill Cornell Medical College, Houston Methodist Hospital, Houston, Texas, USA., Shalaby A; Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, Galway, Ireland., Callagy GM; Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, Galway, Ireland., Glynn SA; Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, Galway, Ireland., Ambs S; Laboratory of Human Carcinogenesis, CCR, NCI, NIH, Bethesda, Maryland, USA., Anderson SK; Cancer Innovation Laboratory, CCR, NCI, NIH, Frederick, Maryland, USA.; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., McVicar DW; Cancer Innovation Laboratory, CCR, NCI, NIH, Frederick, Maryland, USA., Lockett SJ; Optical Microscopy and Analysis Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, and., Wink DA; Cancer Innovation Laboratory, CCR, NCI, NIH, Frederick, Maryland, USA.

Publikováno v: JCI insight [JCI Insight] 2024 May 21; Vol. 9 (12). Date of Electronic Publication: 2024 May 21.

Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patients.

Autor: Ridnour LA; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Cheng RYS; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Heinz WF; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research; Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD., Pore M; Imaging Mass Cytometry Frederick National Laboratory for Cancer Research., Gonzalez AL; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Femino EL; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Moffat R; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research; Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD., Wink AL; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research; Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD., Imtiaz F; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research; Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD., Coutinho L; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD.; Faculdade de Medicina da Universidade de São Paulo and Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, SP, Brazil., Butcher D; Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for the National Cancer Institute., Edmondson EF; Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for the National Cancer Institute., Rangel MC; Faculdade de Medicina da Universidade de São Paulo and Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, SP, Brazil., Wong STC; Houston Methodist Weill Cornell Medical College, Houston TX., Lipkowitz S; Women's Malignancies Branch, CCR, NCI, NIH., Glynn S; Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, Galway, Ireland., Vitek MP; (Mike Duke)., McVicar DW; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD., Li X; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA., Anderson SK; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD.; Basic Science Program, Frederick National Laboratory for Cancer Research., Paolocci N; Division of Cardiology, Department of Medicine, Johns Hopkins University, and Department of Biomedical Sciences, University of Padova, Italy.; Laboratory of Pathology CCR, NCI, NIH., Hewitt SM; Laboratory of Human Carcinogenesis, CCR, NCI, NIH, Bethesda, MD., Ambs S; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA., Billiar TR; Mary and Ron Neal Cancer Center, Houston Methodist Hospital and Weill Cornell Medicine, Houston, TX., Chang JC; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD.; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research; Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD.; Imaging Mass Cytometry Frederick National Laboratory for Cancer Research.; Faculdade de Medicina da Universidade de São Paulo and Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, SP, Brazil.; Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for the National Cancer Institute.; Houston Methodist Weill Cornell Medical College, Houston TX.; Women's Malignancies Branch, CCR, NCI, NIH.; Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, University of Galway, Galway, Ireland.; (Mike Duke).; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA.; Basic Science Program, Frederick National Laboratory for Cancer Research.; Division of Cardiology, Department of Medicine, Johns Hopkins University, and Department of Biomedical Sciences, University of Padova, Italy.; Laboratory of Pathology CCR, NCI, NIH.; Laboratory of Human Carcinogenesis, CCR, NCI, NIH, Bethesda, MD.; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.; Mary and Ron Neal Cancer Center, Houston Methodist Hospital and Weill Cornell Medicine, Houston, TX., Lockett SJ; Optical Microscopy and Analysis Laboratory, Frederick National Laboratory for Cancer Research; Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, MD., Wink DA; Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Dec 23. Date of Electronic Publication: 2023 Dec 23.

Interferon-gamma is Quintessential for NOS2 and COX2 Expression in ER ^- Breast Tumors that Lead to Poor Outcome.

Autor: Cheng RY, Ridnour LA, Wink AL, Gonzalez AL, Femino EL, Rittscher H, Somasundarum V, Heinz WF, Coutinho L, Cristina Rangel M, Edmondson EF, Butcher D, Kinders RJ, Li X, Wong STC, McVicar DW, Anderson SK, Pore M, Hewitt SM, Billiar TR, Glynn S, Chang JC, Lockett SJ, Ambs S, Wink DA

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Apr 06. Date of Electronic Publication: 2023 Apr 06.